SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062997
Filing Date
2023-11-13
Accepted
2023-11-13 16:22:03
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sprb-20230930.htm   iXBRL 10-Q 2458435
2 EX-31.1 sprb-ex31_1.htm EX-31.1 18702
3 EX-31.2 sprb-ex31_2.htm EX-31.2 17231
4 EX-32.1 sprb-ex32_1.htm EX-32.1 9077
5 EX-32.2 sprb-ex32_2.htm EX-32.2 9233
  Complete submission text file 0000950170-23-062997.txt   7337257

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sprb-20230930_pre.xml EX-101.PRE 264514
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sprb-20230930.xsd EX-101.SCH 48281
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sprb-20230930_lab.xml EX-101.LAB 388217
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sprb-20230930_def.xml EX-101.DEF 146201
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sprb-20230930_cal.xml EX-101.CAL 39842
50 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20230930_htm.xml XML 1069910
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39594 | Film No.: 231399118
SIC: 2834 Pharmaceutical Preparations